{"id":"NCT01326026","sponsor":"Novo Nordisk A/S","briefTitle":"Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec Once Daily in Insulin naïve Subjects With Type 2 Diabetes Mellitus When Titrated Using Two Different Titration Algorithms (BEGIN™: ONCE SIMPLE USE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2011-03-30","resultsPosted":"2015-11-17","lastUpdate":"2017-03-06"},"enrollment":222,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]}],"arms":[{"label":"IDeg Simple","type":"EXPERIMENTAL"},{"label":"IDeg Step wise","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to compare the efficacy and safety of NN1250 (insulin degludec (IDeg)) once daily in insulin naïve subjects with type 2 diabetes mellitus when titrated using two different self-titration algorithms (dose individually adjusted) in combination with metformin.","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin (HbA1c)","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDeg Simple","deltaMin":-1.09,"sd":1.05},{"arm":"IDeg Step Wise","deltaMin":-0.93,"sd":0.97}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":45,"countries":["United States","Finland","Germany","Spain"]},"refs":{"pmids":["23812875"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":110},"commonTop":["Nasopharyngitis","Headache"]}}